id,summary
0,"<|user|>
Can you provide more information on the specific questionnaires used to measure central sensitivity, traumatic childhood experiences, mental pain, environmental sensitivity, defense mechanisms, and psychological symptoms of depression, anxiety, and psychosomatics in this study? How are these questionnaires administered and what are their reliability and validity data?"
1,"<|assistant|>
This clinical trial, titled ""Comparison of the Pressure Ulcer Prevention Effects of Two Mattresses With Different Support Surfaces Used in Bedridden Patients,"" aims to investigate the effectiveness of a massage mattress with a cube/block system in preventing pressure ulcers compared to a standard mattress with an orthopedic support surface in bedridden patients at low risk of pressure ulcers as determined by the Braden Scale. Both groups received initial assessments using the Braden Scale and were monitored for four weeks with daily pressure ulcer assessments using the Pressure Ulcer Observation Form. The size of the pressure sore area was measured in square centimeters using the Wound Measurement Ruler. The primary outcome measure was the number of patients without pressure ulcers at the end of the four-week follow-up period. The study utilized a parallel assignment design with triple masking. Eligible participants included bedridden individuals with a low risk rating on the Braden Scale, voluntary informed consent or consent from a legal guardian for unconscious or confused patients, absence of pressure sores upon admission, and a BMI less than or equal to 30. The study excluded patients who's bed was changed in less than ten days after inclusion, patients who were referred, and patients who were discharged during the study.

Note: This summary does not explain how the summary was created, but rather presents a concise and accurate synopsis of the clinical trial information provided."
2,"<|user|>
Can you provide a brief summary of the outcomes the study is hoping to measure, as well as the specific interventions and treatment methods being utilized?"
3,"<|assistant|>
The clinical trial titled ""The Effect of Virtual Reality on Preoperative Anxiety Before Abdominal Surgery"" aims to investigate the impact of virtual reality on managing preoperative anxiety in patients undergoing abdominal surgery. The study will utilize a randomized design with an experimental group that will watch a virtual reality video using mobile virtual glasses, a placebo group that will view the same video without virtual reality, and a control group that will not receive any intervention. The primary outcome measures will include the preoperative anxiety level assessed through a smart bracelet and the Visual Anxiety Scale. The study intends to answer two questions: the frequency of anxiety before abdominal surgery and the effectiveness of virtual reality on anxiety management before abdominal surgery. 

Variables such as preoperative anxiety scale/level, smart wristband with stress level measurement feature, and a patient information form will be used to collect data. The study has a sample size of 96, with 32 patients in each group. The data will be analyzed using parametric or non-parametric tests, depending on normality, with descriptive analysis through mean, standard deviation, and percentage distribution methods. The study has a primary focus on supportive care and does not mask the intervention. The trial excludes individuals not willing to participate, those undergoing surgery other than abdominal, and those unable to communicate in Turkish."
4,"<|assistant|>
Title: Clinical Performance and Safety of Suture-TOOL for Abdominal Wound Closure

Objective: This study aims to evaluate the clinical effectiveness and safety of the Suture-TOOL device for abdominal wound closure during elective open abdominal surgery in individuals who meet the eligibility criteria.

Design: This is a single-arm prospective interventional study with no masking (open-label) to assess the Suture-TOOL device's effectiveness in closing abdominal wounds.

Participants: Men and women aged 18 years or older who are scheduled for elective open abdominal surgery for benign or malignant colorectal disease with a midline incision of at least 12 cm. Individuals with specific exclusion criteria, such as previous abdominal midline surgery, significant physical findings, or diseases that may interfere with the study, are not eligible for participation.

Outcome Measures: The primary outcome measure is the proportion of patients with a suture length-to-wound length (SL/WL) ratio of 4 or more during laparotomy closure. Secondary outcome measures include the stitch count, number of sutures used, closure times, surgeons' comfort, and satisfaction with final closure results.

Time Frame: Primary and secondary outcome measures are measured during the laparotomy closure.

Summary: This clinical study evaluates the Suture-TOOL device's effectiveness and safety in abdominal wound closure during elective open abdominal surgery. The study assesses various outcome measurements, such as the length-to-width ratio of sutures used, comfort, satisfaction, and closure times. The study is limited to individuals who meet the eligibility criteria, excluding those with specific pre-existing conditions or abdominal surgeries."
5,"<|assistant|>
The clinical trial, titled ""Immune Biomarker Study for Salivary Gland Carcinoma,"" aims to examine immune changes in patients with primary salivary gland carcinoma and benign salivary gland tumors, as well as healthy controls with functional diseases of the nose or ear. The study will evaluate the immune matrix, comprising immune cell markers and tumor cell markers, using liquid immune profile-based signatures and tumor associated lymphocytes (TALs). Its primary outcome measure involves assessing changes in the immune matrix and immunophenotyping from baseline to the end of the study period, which is up to five years. Additionally, the study will analyze cytokines, metabolites, and microbiomes in participants' blood, tumor, and stool, respectively. The trial includes individuals aged 18 and above, with sufficient cognitive capacity and suitable for participation, and excludes those with distant metastases, simultaneous second cancers, drug or medication abuse, or inability to understand the study's purposes."
6,"<|assistant|>
The study titled ""Determination of Compliance to Mediterranean Diet, Impacts on Walking and Quality of Life in Multiple Sclerosis"" aims to investigate the adherence to the Mediterranean diet, the use of various nutritional supplements, physical activity habits, walking-related issues, and quality of life in individuals with multiple sclerosis (MS). Participants between the ages of 18 and 65 who have been diagnosed with MS, voluntarily agreed to join the study, and do not have exclusion criteria will be eligible. The study measures compliance with the Mediterranean diet using the 14-item Mediterranean Diet Adaptation Scale (PREDIMED), the quality of life of individuals using the Multiple Sclerosis International Quality of Life Scale, the impact of walking using the 12-item MS Gait Scale, and the disability status using the Expanded Disability Status Scale (EDSS). The study will last for one year, and the outcomes will be measured at specific time points. Keywords related to the study include multiple sclerosis, Mediterranean diet, quality of life, and walking.

Disclaimer: I only summarized the given text and did not explain how I summarized it."
7,"<|assistant|>
The SIIT-CD study is a multicenter, randomized, controlled trial evaluating the effectiveness and safety of selective intensive induction therapy based on ustekinumab clinical decision-making tools in patients with moderate to low responsive Crohn's disease. The study includes individuals aged 18-75 with active disease, and excludes those with extensive bowel resection, significant liver, kidney, or cardiovascular disorders. Participants are randomized to either the SIIT group, receiving intensive ustekinumab induction therapy, or the non-intensive induction therapy group. The primary outcome measure is the difference in clinical response rate at week 24 between the intensive and standard induction regimens. The study has a parallel assignment and is unblinded (open label)."
8,"<|assistant|>
This clinical trial, titled ""The Preference of a Culturally and Linguistic Diverse (CALD) Population for Second Line OAB Therapy: a Discrete Choice Experiment,"" aims to compare the preferences of adults with overactive bladder (OAB) from a diverse population for second-line therapy, specifically between botox and sacral neuromodulation (SNM). Participants will fill in a questionnaire with fictitious therapy options that have different botox and SNM characteristics to determine their preferences. The primary outcome measure is a discrete choice questionnaire, completed in one hour. This study excludes patients with prior SNM or botox treatment."
9,"<|user|>
Can you give me a brief overview of the interventions being compared in this study?"
10,"<|assistant|>
The clinical trial titled ""Fractionated Stereotactic Ablative Body Radiotherapy (SBRT) With FOcal Dose Escalation on Dominant Lesion in Localized Prostate Cancer"" studies the efficacy of SBRT with a focal dose boost on the dominant lesion (DIL) in individuals with intermediate or high-risk localized prostate cancer. The intervention consists of SBRT to the entire prostate (including seminal vesicles) at a dose of 36.25 Gy in 5 fractions, followed by a DIL boost of up to 50 Gy in 5 sessions with additional urethra and bladder trigone sparing constraints. The primary outcome measure is biochemical progression-free survival defined as Phoenix criteria, while secondary outcomes include adverse events, late and acute toxicities, and quality of life assessments using EPIC-26 and CTCAE scales. The study is a single-group assignment, and participants must have an intermediate or high-risk diagnosis, confirmed adenocarcinoma of the prostate, and T2-T3a clinical stage with visible DIL on mpMRI. Exclusion criteria include previous surgery or symptomatic urethral stenosis. The study is designed to measure local control, biochemical progression-free survival, adverse events, late and acute toxicities, and quality of life."
11,"<|assistant|>
The study, titled ""Serious Games as Emerging E-health Interventions for Young People With neurological or Respiratory Disorders (SMILER) - Project@Cnr,"" aims to investigate the use of serious games (SG) as a supportive tool for asthma treatment in children aged 12 to 17 with controlled asthma. Group 1 will play a running-themed SG, which tracks the child's movements and adapts the game's dynamics based on their specific motor skills and heart rate. Group 2 will follow the standard treatment plan without SG. The study's primary outcome is measured using the Pediatric Quality of Life Inventory (PedsQL) and Skills and Difficulties Questionnaire (SDQ-Ita) at 6 months. Secondary outcome measures include the Conserved Transcriptional Response to Adversity (CTRA). Pregnant women, individuals with obesity, major malformations of the respiratory system, active smoking, respiratory infections or immunological, metabolic, cardiac, or neurological diseases are excluded."
12,"<|user|>
Can you provide a summary of the findings from the pilot phase of this study (Experiment 1)? Specifically, what were the effects of acute stress on behavioral and neural PIT effects in participants with and without alcohol use disorder (AUD)? And were there any differences in PIT effects between participants with different stress exposure histories (high versus low chronic stress levels)? It would be helpful to have this information included in the summary."
13,"<|user|>
Please generate a summary of the study design, intervention, and primary and secondary outcome measures for the clinical trial titled ""Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants"" based on the provided text material. Make sure to include details such as study design, intervention, eligibility criteria, participant allocation, primary and secondary outcomes, and time frames for measurement. Use clear and concise language in your summary."
14,"<|user|>
Can you highlight the key factors that make frexalimab a promising treatment for nonrelapsing secondary progressive multiple sclerosis, based on the clinical trial document provided?"
15,"<|user|>
Can you highlight the key differences between the Mishra and modified Millard techniques in the provided clinical trial document?"
16,"<|user|>
Can you provide a brief overview of the study design and the main outcomes being measured?"
17,"<|assistant|>
This clinical trial, titled ""Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure,"" is designed to improve the screening of heart failure and identify patients at risk earlier. It is a randomized, un-blinded study comparing usual care to an intervention group receiving early heart failure testing. The study seeks to determine if early screening and treatment can prevent further decline in high-risk patients. Participants, aged 40 or older with at least two risk factors for heart failure, will be identified through primary care electronic health records and invited to participate. In the intervention group, participants will undergo diagnostic tests including NT-proBNP, AI echocardiography, and electrocardiography if their NT-proBNP level is elevated. The primary outcome will be the number of participants diagnosed with heart failure, as well as outpatient HF visits, urgent HF visits, and HF hospitalizations. Secondary outcomes include the incidence of prescription for guideline-recommended HF therapies in patients diagnosed with HFrEF and HF events in HFrEF. The study will be conducted for six months, and both groups will undergo routine care, with the intervention group receiving additional diagnostic testing."
18,"<|assistant|>
This clinical trial, titled ""Lean Body Weight Scalar for the Anesthetic Induction Dose of Propofol,"" aims to evaluate the effectiveness of using lean body weight instead of total body weight or ideal body weight to calculate the dosage of propofol during anesthetic induction. The study will include patients with a BMI between 18 and 35 and will be observed during anesthesia for 2-6 hours. Propofol infusion will be started based on total body weight, and the relationship between dosage and body mass index will be evaluated. The study is an observational design and will not involve any non-routine procedures. The primary outcome measure is the ratio of propofol dose required for sufficient anesthesia based on both total and lean body weight. The key study terms include lean body weight and propofol intubation conditions."
19,"<|assistant|>
This study is a prospective cohort design to evaluate the effectiveness and safety of letermovir for CMV prophylaxis in heart and lung transplant recipients. Participants will receive either letermovir or standard valganciclovir prophylaxis, and outcomes will be compared between the two groups. The study will measure CMV viral load, frequency of acute cellular rejection, and adverse events such as neutropenia and thrombocytopenia. The study will include adults over the age of 18 and exclude those with certain medical conditions or on certain medications. The study will last up to 365 days following the intervention. The primary outcome is the incidence of CMV viral load exceeding 1,000, CMV syndrome, or tissue invasive CMV disease during the prophylaxis period and 180 days after. The secondary outcomes include the frequency of acute cellular rejection, the proportion of subjects who develop neutropenia, severe thrombocytopenia, or unplanned discontinuation of MMF or azathioprine, and the incidence of incorrect renal dosing of letermovir. Keywords for the study include CMV and thoracic transplant."
20,"<|assistant|>
The clinical trial aims to develop and validate a scale, called the PHYSIOSCORE, to assess the complexity level and physiotherapy care required for hospitalized patients with heart and lung conditions. The study involves ten specialists in physical therapy who define four objectives for the scale: the use of variables in clinical practice, applicability to hospitalized adult patients, feasibility, and inter-examiner reliability. The committee reaches consensus on 106 items through the Delphi technique, divided into three domains: respiratory, imaging, and neuromuscular. A group of ten physical therapists assess two patients simultaneously, with a minimum interval of 15 minutes, to establish concordance and interrater reliability. The study includes 110 patients, with similar inclusion criteria as the previous phase, who are evaluated by the PHYSIOSCORE, EuroSCORE, SAPS 3, and ARISCAT scales three times during hospitalization or until discharge. The study also collects information about patients' characteristics at admission. The primary outcome measures include respiratory and neuromuscular variables assessed over three years. The study's main objectives are to validate the scale's feasibility and inter-examiner reliability and to demonstrate its ability to accurately measure the complexity level and physiotherapy care requirements for hospitalized patients."
21,"<|user|>
Can you provide a concise summary of the SAVAL clinical trial, highlighting its objective, eligibility criteria, and primary outcome measure?"
22,"<|user|>
Can you please summarize the key eligibility criteria for this study on ultra-hypofractionated radiation therapy for breast cancer?"
23,"<|assistant|>
The study aims to investigate the feasibility and preliminary outcomes of a 3-month digital health coaching program for individuals with relapsed or refractory multiple myeloma. Participants will receive weekly coaching calls and a Fitbit device to track their physical activity. The primary outcome is the retention rate of participants completing the coaching program, and the secondary outcome is measuring changes in self-efficacy using the Cancer Behavior Inventory-Brief Form (CBI-B). This study will provide insight into the symptom burden, health self-efficacy, and financial, physiologic, and psychosocial well-being of this patient population using a combination of patient reported, wearable, and clinical data."
24,"<|user|>
Can you provide me with a summary of the study design and outcomes measures?"
25,"<|assistant|>
This is a randomized clinical trial investigating the efficacy of porcine acellular dermal matrix (PADM) in combination with a coronally advanced flap (CAF) for the treatment of localized gingival recessions. The study enrolls participants with RT1 recessions (3-5 mm in height) and at least 2 mm of keratinized tissue width, excluding smokers, pregnant or nursing women, individuals with diabetes or medications interfering with tissue repair, allergies to study components, or a plaque or gingival index greater than 20%. The study features a quadruple masking design, with participants randomly assigned to receive either CAF alone or CAF in conjunction with PADM. The primary outcome measure is recession reduction, assessed at baseline, 6 months, and 12 months, with secondary outcomes including evaluation of keratinized tissue thickness at the same time points."
26,"<|assistant|>
This clinical trial investigates the impact of physical exercise conducted through virtual reality games during hemodialysis sessions on chronic renal patients' heart rate variability modulation. Group A will participate in virtual reality exercises, while Group B will engage in conventional exercise on a stationary bike. After 10 sessions, there will be a washout week, and participants will switch groups. Heart rate, respiratory rate, oxygen saturation, blood pressure, and other measures will be assessed throughout. The study aims to compare changes in heart rate variability modulation between the two groups, determine the virtual environment's impact, and evaluate the relative efficacy of conventional and virtual exercise in improving heart rate variability modulation for chronic renal patients during hemodialysis. Keywords include hemodialysis, physical exercise, virtual reality, Renal Insufficiency, and heart rate variability."
27,
28,"<|user|>
Thanks for generating the summary for the clinical trial document. Can you please add a section about the estimated sample size and the statistical methods used in the study? it would be really helpful for me to have that information."
29,
30,"<|assistant|>
The clinical trial, titled ""Study of the Effectiveness of Central Line Placement Using an Ultraportable Ultrasound Device,"" compares the use of an ultraportable ultrasound device for central line placement to conventional ultrasound methods. The study includes adults scheduled for central line placement in the ICU or preoperatively, excluding pregnant women, suspected jugular thrombosis cases, and emergency procedures with no randomization option. The study's primary outcome measure is the procedure's length, defined as the time between starting the ultrasound scan after sterile protective device placement and fixing the catheter to the skin after confirming its correct position. Both experimental and comparison groups participate, with the experimental group using the ultraportable ultrasound device and the comparison group receiving conventional ultrasound guidance during central line placement. The study's design is randomized, parallel assignment, and single-blind masking only for the operator."
31,
32,"<|user|>
Can you provide more details on how the medical imaging protocol will be carried out at baseline? What specific measures will be taken during the structural Magnetic Resonance Imaging and diffusion weighted images?"
33,"<|assistant|>
The clinical trial titled ""Influence of Gut Microbiome in Gallstone Disease"" aims to examine the gut microbiome profile of adults with newly diagnosed gallstone disease and its correlation with patient outcomes, such as complications and post-operative outcomes. The study will collect clinical and diagnostic data, anthropometry, and blood and imaging results from 75 participants at various timepoints. Stool samples will also be gathered, along with a food diary, at each timepoint for microbiome analysis. The study seeks to identify differences in microbiome composition between patients who experience complications, both pre and post-op, and those who do not, as a preliminary step toward determining interventions to reduce complication instances. Gallstone disease affects approximately 10-15% of people in the UK, resulting in over 65,000 cholecystectomies per year, with complications costing the National Health Service (NHS) more than £25 million annually. This trial aims to contribute to our understanding of gallstone disease and reduce the financial and symptomatic burdens on patients and the NHS."
34,"<|user|>
Can you provide the results of the association analysis between elevated initial APRI value and the occurrence of sepsis-associated liver dysfunction in the MIMIC IV database?"
35,"<|user|>
Can you provide more information on the study design, such as the expected number of participants and the duration of the study?"
36,"<|assistant|>
The clinical trial, titled ""Analyse Of Early Skın To Skın Contact's Impact Upon Maternal-Infant Bondıng And Perceptıon Of Traumatıc Bırth,"" aims to examine the effects of early skin-to-skin contact on maternal-infant attachment and perceptions of traumatic birth. The study enrolled 350 women who had normal deliveries at the Training and Research Hospital in Batman between December 2021 and May 2022. The participants were randomly assigned to either the experimental group, which received skin-to-skin contact, or the control group, which received standard midwifery practices. Maternal attachment was measured using a scale developed by Mary E. Muller in 1994 and adapted to Turkish by Kavlak and Şirin in 2009, and traumatic birth perception was evaluated using a scale developed by Yalnız et al. (2016). Both measures were taken shortly after birth and continued for a month after delivery through telephone interviews. The study was conducted as a randomized controlled experimental study to provide new information to the literature on early skin-to-skin contact's impact on maternal-infant bonding and traumatic birth perception."
37,"<|assistant|>
This clinical trial investigates the efficacy of a sacral erector spinae plane block (ESPB) in managing post-operative pain for patients undergoing lumbar discectomy surgery. The study is a randomized, controlled, double-blind trial with both groups receiving standard general anesthesia. After the surgery, the ESPB group receives the block at the sacral level, whereas the control group does not receive any block. Both groups receive patient-controlled analgesia (PCA) and are monitored for pain scores and opioid consumption for 24 hours. Secondary outcomes include nausea-vomiting and patient satisfaction. The study aims to determine the impact of ESPB on post-operative pain management and potential side effects."
38,"<|assistant|>
This clinical trial aims to develop and validate a non-invasive multimodal ultrasound-based imaging biomarker for myofascial pain, a common contributor to chronic low back pain (cLBP). The study will use deep learning to integrate echogenicity, strain tensors, and ultrasound shear wave elastography measurements of latent and active trigger points, thoracolumbar fascia, and multifidus muscle deformation to create a predictive biomarker for myofascial pain. In the R61 Phase (years 1-3), the biomarker's sensitivity and specificity to classify myofascial components of pain and predict response to treatment will be tested. Eligible participants with cLBP and a myofascial pain component will be classified into one of four categories based on standardized clinical examinations. The study will also examine the presence of substantial myofascial pain. Healthy normals without chronic pain will not receive any interventions. The study includes participants with cLBP who have myofascial pain without trigger points, myofascial pain with latent trigger points, and myofascial pain with active trigger points. Keywords include ultrasound, trigger points, myofascial pain, thoracolumbar fascia, multifidus muscle, and neural understanding network."
39,"<|user|>
Can you provide a summary of the key findings from this clinical trial?"
40,"<|assistant|>
The clinical trial entitled ""Impact of Neuro-linguistic Programming on Schoolchildren's Performance"" explores the potential benefits of NLP techniques on academic outcomes in schoolchildren aged 5-11 years in Lebanon. The trial involves a behavioral intervention utilizing a neuro-linguistic program developed by three specialists, consisting of four sessions for teachers and two for students totalling six sessions. The study measures the impact of NLP on school triggers, behavior, and academic performance using three tools: the ""Identify School Triggers"" questionnaire, the Strengths and Difficulties Questionnaire for parents, and the Vanderbilt Assessment Scale for teachers. The primary outcomes will be evaluated two months after the intervention. The trial follows a supportive care design, adopting triple masking, and has a sample size of 130 children from the same school, attending for at least a year."
41,"<|assistant|>
The clinical trial, ""Effect of Using the ECOX Teaching Tool in the Emergency Department on OSCEs for Medical Students: Randomized Controlled Trial,"" compares the effectiveness of the ECOX tool in improving medical students' performance on service Emergency Care Orientated Clinical Examinations (ECOS) compared to standard learning during the training course. The study includes medical students aged 18 and over in emergency departments who participate in scheduled ECOS at the end of their internship. The control group uses their usual revision methods, while the interventional group uses the ECOX tool available in the emergency department to practice before taking their on-duty OSCEs. Primary outcomes measure student performance on end-of-course OSCEs, and secondary outcomes assess psychological status and student know-how during ECOS. The study runs for 10 weeks and measures STAI-Y scores and behavioral assessment scores during ECOS in each group."
42,"<|assistant|>
This clinical trial evaluates the effects of a web-based health care program on Pulmonary Hypertension (PH) patients' symptom management, social support, activity tolerance, and quality of life. The program aims to improve social support, self-care ability, active tolerance, symptom distress, anxiety, and depression in PH patients. The study includes patients with PH aged 20-90 years, who are diagnosed with Group1 or Group4 PH, have internet or mobile internet access, are aware of their diagnosis, are mentally stable, and do not have alcohol or drug addiction. Usual care remains the control group. The study employs a randomized, paralleled, double-blind, block-randomized design, and measures PH symptoms, social support, activity ability, and quality of life at six months using standardized tools such as PAHSS, MSPSS, 6MWD, and CAMPHOR. The trial aims to determine the effectiveness of the web-based health care program for PH patients."
43,"<|assistant|>
This clinical trial, titled ""Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families"", aims to compare the impact of using long term mechanical ventilation support (LTMV) on the overall quality of life of ALS patients and their families with those who do not choose LTMV. Primary outcomes are measured by the Quality of Life Scale at four time points, while secondary outcomes include health-related quality of life, caregiver burden, disease-specific quality of life, and health-related quality of life assessed by various scales. Participants include ALS patients with progression of the disease and their partners and children who can communicate in Norwegian. There is no mention of a comparison group for the patients who decline LTMV, implying that they will not be included in the study analysis. The study is not blinded or placebo-controlled, and its design is non-randomized with parallel assignment for both groups."
44,"<|assistant|>
This clinical trial, titled ""Neurologic Deficits and Recovery in Chronic Subdural Hematoma,"" aims to assess neurological deterioration and recovery in patients with chronic or subacute subdural hematoma undergoing surgical evacuation. Participants will undergo ECoG monitoring, a diagnostic test, to detect spreading depolarization, which may indicate a higher risk of deterioration. The study will measure postoperative neurologic deterioration using the Markwalder grading scale and Glasgow coma scale. Secondary outcomes will include functional, cognitive, and quality of life assessments at 30, 90, and 180 days post-surgery. The study is a single-arm intervention, with no placebo or comparison group. Exclusion criteria include emergent surgery needs and severe baseline disability. The study is not accepting healthy volunteers."
45,"<|assistant|>
The study, titled ""Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS, After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial,"" aims to compare the effectiveness of annual versus semi-annual infusions of ocrelizumab in patients with multiple sclerosis who have not experienced a relapse for at least 18 months and have active MS, RR or SP form. The primary outcome measure is the percentage of patients with no new or enlarged T2 lesions on MRI at 24 months, with MRI readings performed by an independent radiologist blinded to the treatment arm. Patients must be 18 years or older, have active disease, require follow-up MRI, and be eligible for social insurance. The study is a multicenter randomized controlled trial with a parallel assignment and single masking design, and will last for 2 years. The intervention groups involve either annual or semi-annual infusions of ocrelizumab, otherwise known as Ocrevus. The study excludes patients with certain medical conditions, pregnant or breast-feeding women, and those already receiving systematically spaced doses of ocrelizumab."
46,"<|assistant|>
The SPARCOL study is a clinical trial studying the effectiveness of the Combined Endoscopic Laparoscopic Surgery (CELS) procedure, which is a minimally invasive organ-sparing procedure for elderly, frail patients with early-stage colon cancer. The study is comparing CELS to standard colon resection surgery in terms of postoperative recovery, physical function, and quality of life using various assessments and questionnaires, including the Quality of Recovery 15, 30-second sit-to-stand test, six-minute walk test, EuroQol EQ-5D-5L, and EuroQol EQ-C30-CR20 questionnaire. The study is also measuring the incidence of intraoperative and postoperative complications, long-term oncological outcomes such as disease-free survival, overall survival, and recurrence, as well as hospital readmissions, 90-day mortality, and length of hospital stay using the Clavien-Dindo classification and the Comprehensive Complication Index. The study is recruiting patients aged 75 and older with a PS score of 1 or ASA score of 3, Macroscopically or pathologically confirmed colonic adenocarcinoma, clinical T1/T2 N0 M0, colonic tumor location not exceeding the ileal valve, and suitable for CELS resection according to Multidisciplinary Team (MDT) judgement. The study's primary outcome measure is the change in patient-reported postoperative recovery using the Quality of Recovery 15 assessment. The trial's protocol is outlined in detail, including the timelines for assessments and follow-up periods."
47,"<|assistant|>
This clinical trial, titled ""Effectiveness of Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in People With Neuromuscular Disease or Neurodisability: a Phase 2 Open Label Pilot Study,"" aims to investigate the effectiveness of nebulised 6% hypertonic saline in reducing respiratory exacerbations in individuals with neuromuscular diseases or neurodisabilities, specifically those who have experienced at least one exacerbation requiring antibiotic therapy within the past year. The study will enroll individuals aged 5 and above who are able to tolerate nebulised hypertonic saline. Participants will be randomized to receive either nebulised hypertonic saline or nebulised normal saline as a placebo comparator. The primary outcome is the number of antibiotic courses for respiratory infections over a 52-week period, while additional outcomes include lung function tests, airway inflammation, bacterial diversity, ease of airway clearance, health-related quality of life, treatment and family impacts, and health economics measurements. The study is a phase 2, open-label pilot study with no masking."
48,"<|user|>
Can you provide me with a summary of the inclusion and exclusion criteria for the clinical population in this study?"
49,"<|assistant|>
The clinical trial aims to develop a new metabolic imaging approach called activity magnetic resonance imaging (aMRI) for evaluating neurological diseases in patients with gliomas. The trial will compare the aMRI parameter k⁰⁎*V in tumor regions with normal-appearing brain regions using a standard metabolic imaging approach, ¹⁸FDG PET, as a reference. The primary objective is to determine if aMRI accurately distinguishes tumor regions from normal brain regions. The study will also compare the aMRI metabolic parameter in different normal-appearing brain sub-regions unaffected by tumor and evaluate its correlation with ¹⁸FDG PET data. Secondary objectives include distinguishing the contrast-enhancing ring region indicating the metabolically active tumor periphery from the less viable and/or necrotic tumor core and comparing how aMRI metabolic parameters change in disease lesions with different disease types, stages, and treatments. Patients with gliomas who require MRI and ¹⁸FDG-PET imaging are eligible to participate. The study involves receiving ¹⁸FDG and gadoterate meglumine IV and undergoing simultaneous MRI and PET scanning for 45-60 minutes. The outcome measures include mean values of k⁰⁎*V in tumor regions, tumor periphery and core regions, and different normal-appearing brain sub-regions, as well as correlation with ¹⁸FDG PET data."
50,
51,"<|assistant|>
This clinical trial compares the effectiveness of extracorporeal shock wave lithotripsy (ESWL) alone and ESWL in combination with tamsulosin therapy for treating upper ureteric stones in patients with a history of stone formation less than 6 months ago, stone size between 6 and 15 mm, and no urinary tract infection. Exclusion criteria include multiple stones, strictures, prior unsuccessful ESWL, or concomitant use of certain medications. The study's primary outcome measure is stone clearance, evaluated 4 weeks after treatment, with a primary purpose of treatment. The study design is a randomized, parallel assignment with single masking."
52,"<|assistant|>
This clinical trial, titled ""Interventional Therapy of Tracheal Stenosis After Percutaneous Tracheotomy,"" aims to investigate the effectiveness of interventions for tracheal stenosis that develops after a percutaneous tracheotomy. The study includes participants with tracheal stenosis but excludes those who have undergone surgical tracheotomy or are pregnant or nursing. The study's primary outcome measure is the rate of successful decannulations after intervention up to hospital discharge, while secondary outcome measures include technical success, number of interventions required, type of intervention, clinical success, and additional treatment needed. The study will investigate these measures for a period of 12 months."
53,"<|assistant|>
The DRIVE-Mind II study, taking place in Vietnam, is a community-based psychiatric intervention for people who inject drugs (PWID) with psychiatric disorders, such as depression, psychosis, or suicidal risk. Participants diagnosed with these conditions during the ANRS 12353/NIDA ROI DA 041978 DRIVE study will receive psychiatric consultations and medication for free on community-based organization (CBO) sites, as well as support from trained CBO members. The control group consists of PWID without psychiatric disorders who will undergo a one-year follow-up. Both groups will receive harm reduction services and linkage to care when needed. The study's primary outcomes include viral exposure, severity of substance use, and quality of life, with secondary outcomes including adherence to HIV treatment, factors related to access to care, methamphetamine-induced psychotic disorders, HIV and HCV incidence, and the cost of the community-based psychiatric intervention. The study aims to compare these outcomes between the two groups."
54,"<|user|>
Based on the provided clinical trial document, could you please provide a brief summary of the effectiveness of Photodynamic Therapy in disinfecting root canals and treating apical lesions, as compared to conventional endodontic treatment? The summary should include the key aspects of the study and the results obtained. Also, please mention any major limitations or drawbacks of the study."
55,"<|assistant|>
This clinical trial investigates the effectiveness of a treatment plan for individuals with autism spectrum disorder (ASD) who also have concurrent psychiatric disorders such as PTSD, OCD, depression, anxiety, and panic disorder. The intervention includes a combination of psychotherapy, cognitive-behavioral therapy (CBT), and medication, specifically sertraline and duloxetine. The study measures various psychiatric symptoms using standardized scales, as well as heart rate and blood pressure, for a period of 90 days. The treatment's impact on behavioral satisfaction, proactive social behavior, and the hypothalamic-pituitary-adrenal (HPA) axis in daily life is also studied. The study aims to help individuals with ASD manage their complex psychiatric conditions through a tailored treatment approach."
56,"<|user|>
Can you provide a brief summary of the DIAMOND study's objectives and interventions?"
57,"<|user|>
Can you provide some information on the expected participant enrollment and duration of the study? Also, are there any specific qualifications required for the psychologist administering the CPT intervention?"
58,
59,"<|user|>
Can you provide me with a summary of the primary and secondary outcomes in this clinical trial on pulsed-field ablation for persistent atrial fibrillation?"
60,
61,"<|user|>
Can you provide me with a brief summary of the study design and goals for the clinical trial ""A Study to Compare Two Dosing Regimens for a New Malaria Vaccine""?"
62,"<|assistant|>
The study, titled ""Medical Decision Making in Multiple System Atrophy: Developing Personalized Best Medical Care With Integrated Telemedicine and Mobile Palliative Care for Individuals With Multiple System Atrophy,"" is a 18-month, monocentric, randomized, rater-blinded study that aims to evaluate the impact of a multidisciplinary, personalized symptomatic treatment plan with integrated mobile palliative care and telemedicine on the quality of life (QoL) of individuals diagnosed with multiple system atrophy (MSA) compared to a historical European MSA cohort. The study enrolls 46 individuals with MSA meeting all inclusion and none of the exclusion criteria. Participants undergo a baseline examination, which includes clinical, psychological, and neuro-rehabilitation assessments, and complete a falls protocol and blood pressure and bladder diaries prior to the visit. Based on the results, individualized treatment plans are prepared, which may include mobile palliative care interventions for wheelchair-bound individuals. The study includes two study arms: (1) the personalized best medical care arm, which includes a multidisciplinary, personalized symptomatic treatment plan, and (2) the personalized best medical care plus telemedicine arm, which includes monthly telemedicine neurological, psychological, and rehabilitation consultations, as well as additional personalized best medical care options. The study measures changes in QoL, motor and non-motor symptoms, and healthcare preferences, and examines the need for medical, psychological, and neurorehabilitation interventions, healthcare professionals' and patients' satisfaction with individualized treatment plans and interventions, healthcare costs, and caregivers' QoL and burden. The study is funded by the ""Europäische Region Kärnten/Koroška"" and ""Tiroler Zukunftsfonds"" under the ""EUROPEAN REGIONAL DEVELOPMENT FUND--INTERREG VI-A Austria--Slovenia"" program."
63,"<|assistant|>
This clinical trial, titled ""A Study of the Genetic Determinants of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature,"" aims to investigate the genetic factors that influence response to growth hormone therapy in children with idiopathic short stature. The study does not involve any intervention or treatment and involves two participant groups: good responders and poor responders, defined by changes in height Standard Deviation Score (SDS) after one year of growth hormone therapy. Both groups will have a single study visit to provide biological samples. The study will measure the frequency of genetic variants and their enrichment in genes or pathways between the two responder groups, with an odds ratio as the primary outcome measure and a count as the secondary outcome measure, one year after growth hormone therapy. Eligibility criteria include a diagnosis of idiopathic short stature, prepubertal status at initiation of growth hormone therapy, and impaired height prior to therapy. Exclusion criteria include prior participation in the study, concomitant illness, and medication use that could influence response to growth hormone therapy. The study is designed for participants aged 3-11 years of any sex. No treatment is provided to the participants as part of this study."
64,"<|assistant|>
This clinical trial, titled ""Impact of Neurochecks on Sleep in Critically Ill Adults,"" focuses on examining the effect of the frequency of neurochecks, which are neurological exams performed on critically ill patients, on their sleep. The trial includes adult patients who have undergone elective coiling of unruptured cerebral aneurysms, excluding those with sleep disorders, cognitive impairment, or severe arterial pathology. Participants are randomized to receive either hourly or every-other-hour neurochecks. The primary outcome measure is sleep efficiency, and secondary outcomes include wakefulness, REM sleep, deep sleep, arousals, and subjective sleep quality. This study aims to prevent sleep disturbances in critically ill patients through the implementation of behavioral interventions."
65,"<|assistant|>
This clinical trial aims to investigate the prognostic significance of extranodal extension (ENE) in head and neck cancer, also known as iENE when detected radiologically. The study will assess the accuracy of identifying iENE by radiologists in real-world situations by comparing it with the gold standard of pathological evaluation (pENE). The study will also evaluate the overall survival and recurrence rates based on the presence of iENE and pENE. Additionally, the study will risk-stratify patients based on their HPV status and N stage. Secondary outcomes include determining radiological features of iENE that best correlate with pENE, assessing the utility of existing diagnostic classification systems, and measuring interobserver variability in grading radiographic ENE. The study will include patients with head and neck squamous cell carcinoma treated between 1999 and 2020, with follow-up until December 2023."
66,"<|assistant|>
The clinical trial titled ""Bedside Bone Biopsy Versus Conventional Bone Biopsy for Management of Diabetic Foot Osteomyelitis: an Open-label Controlled Randomized Non-inferiority Trial"" aims to compare the efficiency and safety of bedside blind bone biopsy (BBB) and conventional bone biopsy (CBBI) in managing diabetic foot osteomyelitis (DFO). The study includes participants with diabetes and a suspicion of DFO, diagnosed based on IWGDF 2019 guidelines. The primary objective is to demonstrate non-inferiority of BBB compared to CBB in DFO remission without surgery at 1 year. Secondary objectives include comparing clinical efficacy, microbiological culture results, safety, and DFO remission according to BB results (positive or negative). The study also evaluates the costs and quality-adjusted life years (QALYs) associated with both procedures. The trial is a randomized, open-label, parallel-group assignment study with a total duration of 12 months for follow-up. The remission of DFO, clinical efficacy, microbiological results, adverse events, costs, and QALYs are the measures being assessed. Keywords include bedside bone biopsy, conventional bone biopsy, diabetes, Diabetic Foot Ulcer (DFU), and diabetic foot osteomyelitis (DFO)."
67,"<|assistant|>
The ""African Americans (AA) Communities Speak"" study aims to address the disparity in quality end-of-life care for AA individuals by creating a training program for clinicians caring for AA older adults with serious illnesses. The program, called ""Caring for Older African Americans,"" will be adapted from the original prototype designed for rural Southern AA older adults. In the adapted program, urban-dwelling Southern and Northern AA older adults will learn about cultural values and preferences related to end-of-life care via a comparative ethnographic study. The program will also include community-developed storytelling videos for empathizing with experiences of racism in end-of-life care, guidelines for culturally concordant end-of-life care delivery, and a modified implicit bias management program for goals of care communication. The training will be conducted in partnership with two distinct AA communities in the South and the North using a cluster randomized trial design with a stepped wedge approach. The primary outcome measure will be patient/family perception of therapeutic alliance using The Human Connection Scale. Secondary outcome measures will include family-reported goal-concordant care and clinicians' knowledge, awareness, and confidence in providing culturally concordant end-of-life care. Distinguishing features of the program include its focus on addressing cultural concordance, systemic racism, and implicit bias management simultaneously."
68,"<|assistant|>
The clinical trial titled ""Assessment of Genomic Alterations and Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers"" aims to analyze the molecular profiles of HPV+ and HPV- head and neck cancers through genetic analyses such as PCR, immunohistochemistry, and immunolabelling. The study aims to identify predictive markers for more effective and less invasive treatments for HPV+ head and neck cancers, as patients with this type of cancer are currently treated the same as HPV- head and neck cancer patients despite having a better prognosis. The study will analyze the molecular profiles of 87 hotspot genes, 48 full-length genes, 43 copy number genes, and 51 gene fusion genes in biopsies from patients with oropharyngeal or oral cavity squamous cell carcinomas who test positive or negative for HPV. The primary outcome measure of the study is the molecular profile of tumors, which will be determined on the first day of the study. The study excludes head and neck cancer patients with diagnoses other than oropharyngeal or oral cavity squamous cells carcinomas, and participants should have a biopsy or excision available and sufficient for molecular analysis. The study is not open to healthy volunteers."
69,"<|user|>
Can you provide a clear explanation of the secondary outcome measures mentioned in the study plan section of the document?"
70,"<|assistant|>
The clinical trial, titled ""Soft Tissue Contour and Radiographic Evaluation of Ridge Preservation Using Different Techniques,"" aims to compare the effectiveness of four different techniques for alveolar ridge preservation after tooth extraction. The trial includes participants over the age of 20 who require dental implant or denture fabrication after tooth extraction due to malocclusion or broken teeth. The four techniques being compared are:

1. Spontaneous healing (control)
2. Bone particle grafted with subepithelial connective tissue graft
3. Bone particle grafted with vascularized interpositional periosteal connective tissue graft
4. Bone particle grafted with collagen membrane or Cytoplast

The study will measure soft tissue and hard tissue alterations using cone-beam computed tomography and STereoLithography files for up to 12 months. The primary outcomes being evaluated are soft tissue and hard tissue alterations, while secondary outcomes include changes in keratinized tissue width measured with a periodontal probe and patient satisfaction measured through a Visual Analogue Scale questionnaire. The trial is a randomized, double-blind study that will include participants who meet certain criteria, including no contraindications for invasive dental procedures and healthy soft tissue."
71,"<|assistant|>
This clinical trial is investigating the levels of pro-inflammatory cytokines in women with Essure® contraceptive implants, as well as in control groups with no endometriosis/adenomyosis or with endometriosis/adenomyosis. The primary outcome measure is the level of cytokine IL10 in peritoneal fluid, which will be compared between the groups. The study involves women over 18 who underwent removal of Essure® implants, as well as control patients who underwent benign laparoscopic gynecological surgery. The data will be collected for an average of 4 months and the study is specifically looking at pro-inflammatory cytokines in relation to Essure® implants. Keywords related to the study include contraceptive implants and pro-inflammatory cytokines."
72,"<|assistant|>
This clinical trial aims to investigate the impact of ursodeoxycholic acid (UDCA) on COVID-19 infection and its clinical outcome in patients with primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH). The study is a two-way cohort design, which includes both retrospective and prospective observation of enrolled PBC and AIH patients from January 2021 to December 2023 at Beijing Ditan Hospital. Demographic data, medical history, treatment, vaccination, COVID-19 infection and its symptoms, biochemical indicators, imaging examinations, and COVID-19 nucleic acid and antibody tests are collected. Patients with COVID-19 infection during the prospective observation period are followed up for infection severity, hospital stay, virus negative time, and clinical outcome. The primary outcome is the incidence of COVID-19 infection, and secondary outcomes include disease severity, COVID-19 nucleic acid disappearance time, and infection outcome. The study aims to compare the difference of COVID-19 infection rate, disease severity, clinical biochemical indicators, hospital stay, and prognosis between UDCA treated and non-UDCA treated patients, and to explore the impact of UDCA on the occurrence, incidence, and outcome of COVID-19 infection."
73,"<|assistant|>
The study, titled ""Effect of Preoperative Prone Position Training on Postoperative Pulmonary Complications in Patients Undergoing Laparoscopic Colorectal Surgery,"" aims to investigate whether preoperative prone position training can decrease the incidence of postoperative pulmonary complications (PPCs) in patients undergoing laparoscopic colorectal cancer surgery. The study is a randomized controlled trial involving eligible participants aged 18 or older with clinical diagnosis of colorectal cancer, excluding those with specific conditions. Participants are randomized into either the experimental group (prone position training, PPT) or the placebo comparator group (control group, C). The experimental group receives daily prone position training for at least 3 days before surgery, while the control group receives standard perioperative care without any prone position training. The study measures the incidence of PPCs, including pneumonia, atelectasis, pleural effusion, respiratory failure, and unplanned intubations, during the first 7 days after surgery. Secondary outcomes include arterial partial pressure of oxygen (PaO2), extubation time, peak airway pressure, arterial partial pressure of carbon dioxide (PaCO2), and oxygenation index (OI) at preoperative, intraoperative, and postoperative time points. The study is guided by the Consolidated Standards of Reporting Trials (CONSORT) statement and is being conducted at the First Affiliated Hospital of Chongqing Medical University in accordance with good clinical practice (GCP). Participants provide written informed consent before enrollment."
74,"<|assistant|>
This study, titled ""Evaluation of Safety and Efficacy of BLEX 404 Oral Liquid Combined with Pemetrexed + Cisplatin Therapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with EGFR Wild-Type,"" aims to determine the safety and efficacy of BLEX 404, an oral liquid drug, in combination with Pemetrexed and Cisplatin therapy for advanced or metastatic NSCLC patients who have not undergone prior chemotherapy, have non-squamous histologies, and are EGFR wild-type. The study has two phases: Phase I involves dose escalation to establish the safe and tolerable dose level of BLEX 404, while Phase II evaluates the efficacy of the recommended dose level determined in Phase I. The primary outcome measures include detecting dose-limiting toxicities (DLTs) in the first cycle of combination use and determining the recommended dose level (RDL) in the first cycle of combination use. Other outcome measures include overall response rates and changes in the quality of life, as assessed by a standard questionnaire (EORTC QLQ-C30). Overall, the study seeks to explore the potential benefits and risks of using BLEX 404 in combination with standard chemotherapy for NSCLC patients with specific characteristics."
75,"<|assistant|>
The ""AGE SELF CARE: Promoting Healthy Aging Through a Group Visit Program"" study is a pilot feasibility and acceptability study designed to test an eight-week virtual group visit program for pre-frail older adults over the age of 65. The goal of the program, called AGE SELF CARE, is to promote healthy aging through education and behavioral change in the areas of self/health, home environment, and community. The program consists of 90-minute weekly sessions led by an aging expert and covers topics such as healthy lifestyle education, home adaptation, and frailty prevention. The study will measure recruitment rates, attendance, satisfaction, and compliance with the program, as well as secondary outcomes including frailty index, loneliness, self-reported health, physical activity, self-efficacy, depression, anxiety, sleep quality, and mobility. Keywords related to the study include pre-frail, healthy aging, yoga, mind-body, and the Short Physical Performance Battery (SPPB). The study is being conducted at the BWH Osher Clinical Center for Integrative Medicine in collaboration with Harvard Medical School. The study aims to gather data to inform the development of AGE SELF CARE at the stage I level of the NIH stage model for behavioral intervention development."
76,"<|user|>
Can you please provide me with a summary of the main findings of the Pan-European Study on Geriatric Rehabilitation After COVID-19 Disease? I'm not interested in the study methods or detailed participant criteria, just the key results and insights uncovered in the study."
77,"<|user|>
Can you provide more details on the secondary outcomes measures of immunogenicity after COVID-19 vaccination and herpes zoster vaccination in the PREPARE-iVAC Trial?"
78,"<|assistant|>
The clinical trial, titled ""Effect of Resistance Exercises on Liver Enzymes Post Burn,"" is a study involving sixty patients with partial thickness burns covering 30-50% of their bodies, aged between 20 and 45 years. They will be randomly assigned to either a study group or a control group. The study group will receive resistance exercises using dumbbells and sandbags, in addition to their physical therapy program and medical treatment, for 8 weeks, 3 times a week. The control group will receive their physical therapy program and medical treatment without resistance exercises. The primary outcome measure is the reduction in plasma liver enzymes (AST and ALT) levels after two months. The study design is a parallel assignment, randomized, double-masked treatment trial. The exclusion criteria include cardiac diseases, burns of the sole of the foot, exposed tendons, lower limb amputation, history of liver diseases, and a body mass index below 30. The study intends to determine the effectiveness of resistance exercises in reducing plasma liver enzymes levels post-burn."
79,"<|assistant|>
The study ""Efficacy of Upper Trapezius Stretching on Neck Pain, Range of Motion, and Disability in Patients with Cervical Spondylosis: A Randomized Controlled Trial"" aims to investigate the effectiveness of upper fibers of trapezius stretching on neck pain, range of motion, and disability in individuals with cervical spondylosis. The study is a randomized controlled trial with two arms: an experimental group that receives upper fibers of trapezius stretching in addition to standard care, and a control group that receives standard care alone. Measurements will be taken at baseline, 4 weeks, and 3 months regarding neck pain intensity, neck range of motion, and neck disability index using self-reported numerical rating scales and a goniometer. Exclusion criteria include recent neck trauma, fractures, or surgery, and concurrent medical conditions that could affect neck pain and range of motion. The study will only recruit individuals with a confirmed diagnosis of cervical spondylosis aged between 40 and 65 years. The intervention involves specific stretching exercises designed to target the upper fibers of the trapezius muscle, supervised by a licensed physical therapist. The study is aimed at improving neck range of motion, reducing pain intensity, and reducing disability in patients with cervical spondylosis."
80,"<|assistant|>
The clinical trial titled ""Effectiveness of Tecarterapy on the Performance of Amateur Athletes"" aims to investigate the impact of tecartherapy, a type of deep thermotherapy using electrical currents and electromagnetic fields, on the functional performance of amateur athletes aged 18-30 who engage in athletics or field sports that involve sprinting. The study will allocate participants into an experimental group, receiving a tecartherapy procedure on both legs with a T-Plus Wintecare® machine, or a sham group, undergoing the same procedure but with the machine's power turned off. The study will measure changes in 30-meter sprint time, countermovement jump height, isometric leg extension force, and electromyographic activity during sprinting, jumping, and isometric leg extension using validated devices. The results will be compared between the groups at baseline and post-intervention to determine the effectiveness of tecartherapy on sports performance in amateur athletes."
81,"<|assistant|>
This clinical trial aims to compare the levels of cell-free DNA (cfDNA) in patients with endometriosis undergoing medical assistance for conception (MAC) through in vitro fertilization (IVF) with those in patients with other infertility causes. Blood samples (10 ml) will be drawn from participants before and after IVF stimulation, and cfDNA will be extracted and quantified using real-time polymerase chain reaction (PCR). The study will also measure the cfDNA levels in follicular fluid on the day of oocyte puncture. The primary outcomes are the cfDNA rates in serum before IVF stimulation and in follicular fluid on the day of puncture. Secondary outcomes include the number and quality of oocytes, the blastulation rate, and the number of clinical pregnancies and live births. The study excludes patients who are followed for other inflammatory diseases or premature ovarian failure, and patients who are not eligible for MAC. The study's objective is to investigate the potential relationship between cfDNA levels and oocyte quality in patients with endometriosis undergoing MAC."
82,"<|assistant|>
The study is a comparative prospective study examining maxillary implant overdentures retained by bars or Locator attachments in fully edentulous patients with a history of problems with their conventional denture. It has a 10-year follow-up duration, and the primary outcome measure is the change in peri-implant marginal bone level. Secondary outcome measures include implant and overdenture survival, peri-implant mucosa health, plaque score, peri-implant mucosa condition, and patient satisfaction. Patients were eligible if they were 18 years or older, had sufficient bone volume, and adequate interocclusal space for placement of an overdenture. This study aims to compare treatment outcomes between bar-retained and Locator-retained implant overdentures to determine which system provides better results in the long term."
83,"<|user|>
Can you provide a clear summary of the intervention methods included in the study for the experimental group?"
84,"<|assistant|>
The trial, titled ""Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial,"" aims to compare the effectiveness of cognitive stimulation therapy (CST) to standard care in individuals with mild to moderate dementia or mild cognitive impairment. Eligible participants have MoCA scores between 10 and 26 or equivalent cognitive assessments. The intervention group receives a referral for CST from their physician, while the control group receives standard care only. The study measures clinical meaningful cognitive decline and improvement using the Montreal Cognitive Assessment (MoCA) at baseline and 6-month follow-up. Secondary outcomes include referral acceptance rate, participant attendance, and attrition. The trial is a two-armed pragmatic trial with randomized allocation, an open-label design, and a follow-up period of 6 months."
85,
86,"<|assistant|>
The study titled ""Personalizing Disordered Eating Treatment Using Mobile Technology: Self-Guided, Personalized Treatment for Women"" aims to evaluate the effectiveness of a self-guided, personalized treatment for women with disordered eating via mobile technology. Participants who endorse significant disordered eating symptoms, aged between 18-65, and proficient in English will participate. The intervention involves two weeks of smartphone self-monitoring to identify target problems followed by the provision of two self-guided modules of personalized treatment directly to their smartphones. Primary outcomes include disordered eating symptoms, anxiety, depression, clinical impairment, and quality of life assessed using standardized questionnaires up to 8 weeks post-intervention. Keywords associated with this study include therapy, treatment, anorexia nervosa, bulimia nervosa, binge eating disorder, atypical anorexia nervosa, and other specified feeding and eating disorders. It follows a single-group assignment design with open-label masking."
87,"<|assistant|>
The study, titled ""Evaluation of the CAD EYE System for the Detection of Colorectal Neoplastic Lesions in Patients With Lynch Syndrome,"" aims to assess the effectiveness of the CAD EYE system for screening for neoplastic lesions in individuals with Lynch Syndrome. It is a clinical trial with a randomized parallel assignment and single masking design, enrolling eligible participants with confirmed pathogenic mutations for Lynch Syndrome. The study includes two arms: the experimental group will undergo colorectal cancer screening with the CAD EYE system, while the reference group will undergo screening with indigo carmine chromoendoscopy. The primary outcome is the comparison of the adenoma detection rate between the two groups, and secondary outcomes encompass detection rates of specific lesions, the diagnostic performance of CAD EYE, the resect and discard strategy in Lynch Syndrome, and procedure times. The study's keywords include artificial intelligence, Lynch Syndrome, CAD EYE, adenoma detection rate, and colorectal screening."
88,"<|assistant|>
The study titled ""Use of a Water Soluble Conast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction"" is a prospective observational study conducted at nine children's hospitals. The study involved children aged 1 to 20 years diagnosed with an adhesive small bowel obstruction who underwent a trial of nonoperative management (NOM) on hospital admission. Children with peritonitis, incarcerated or internal hernia, active intra-abdominal malignancy, inflammatory bowel disease, recent abdominal operation, pneumatosis, pneumoperitoneum, or a contrast allergy were excluded. Children under one year of age were excluded due to a lower success rate of NOM in this age group.

The study was powered to detect a 15% difference in operative rate between the contrast and no contrast groups based on adult literature. The study design involved two arms, contrast group and no contrast group. The contrast group received an enteral contrast challenge with contrast dilution, volume, and agent not standardized due to hospital-specific formularies. The contrast agent used was either diatrizoate meglumine (1940 mOsm/kg) or ioversol (702 mOsm/kg). Patients received 30-200ml of contrast followed by X-rays at 8-12 hours and 24 hours after contrast administration.

The study collected data through the Research Electronic Data Capture (REDCap) software tool hosted at the University of Colorado. Data collected included patient demographics, medical and surgical history, clinical presentation, laboratory studies, imaging, management approach, complications specific to contrast administration, length of hospital stay, need for operation, indications for operation, and subsequent postoperative course and complications.

Statistical analyses included descriptive statistics, group differences tests, and logistic regression. The study aimed to compare the need for operation between the contrast and no contrast groups, adjusting for age, body mass index, volume of contrast, and previous laparotomies. A subset analysis was also performed among patients who received enteral contrast, comparing differences based on contrast agent and final osmolality. Comparisons were made between patients who were successfully managed nonoperatively and then between those patients who required abdominal operation, based on contrast status.

The primary outcome measure of the study was the number of patients who required an operation due to failure of nonoperative management. The study also measured total hospital length of stay in days among patients successfully managed nonoperatively and adverse events resulting from contrast administration. 

Terms used in the study include adhesive small bowel obstruction, enteral contrast challenge, contrast agent, contrast dilution, contrast volume, Pediatric adhesive small bowel obstruction, pneumatosis, pneumoperitoneum, and contrast allergy. The study involved pediatric patients aged 1 to 20 years diagnosed with an adhesive small bowel obstruction."
89,"<|assistant|>
This trial is a Phase 1, single-center, open-label, randomized, parallel group, single-dose study to compare the pharmacokinetics (PK) of subcutaneous itepekimab administered using an autoinjector (AI) versus a prefilled syringe (PFS) in healthy participants. The primary outcomes measure the maximum plasma concentration (Cmax), area under the plasma concentration-time curve (AUC) from 0 to the last observable time point (AUClast), and the AUC from 0 to infinity (AUC) of itepekimab. Secondary outcomes include the time to reach Cmax (tmax), AUC from 0 to 28 days, terminal half-life (t1/2), apparent total body clearance (CL/F), and apparent volume of distribution at steady state (Vss/F). The study also aims to assess the incidence of anti-itepekimab antibodies and adverse events, including injection site reactions, serious adverse events, and adverse events of special interest. Participants must be 18-65 years old and able to provide informed consent. Both treatment arms (AI and PFS) use the same medication, Itepekimab, with slight differences in administration methods. This study is designed to investigate the efficacy and safety of AI versus PFS administration methods. The study duration is approximately 141 days for each participant from the first dose to the end-of-study visit."
90,"<|user|>
Can you provide some insights into the population that is eligible to participate in this study based on the inclusion and exclusion criteria?"
91,"<|user|>
Can you provide a brief summary of the study design and outcomes being measured?"
92,"<|assistant|>
The clinical trial, titled ""Pharmacokinetics Study of Rivaroxaban and Apixaban in Cancer Patients,"" aims to investigate the pharmacokinetic profile of rivaroxaban and apixaban in adult cancer patients with venous thromboembolism or atrial fibrillation from a real-world setting. The study will identify factors that influence the pharmacokinetic profile of these direct oral anticoagulants (DOACs) in cancer patients, with a view to identifying drug-drug interactions that may affect their safety and efficacy. The study will enroll cancer patients who are either currently receiving or have received DOACs for the treatment of venous thromboembolism or atrial fibrillation. The study's primary endpoint is a population pharmacokinetic evaluation that estimates the area under the curve (AUC) of rivaroxaban and apixaban for three years. Secondary endpoints include safety evaluations for major bleeding or thromboembolic events that will be followed up for three years as well. This study seeks to provide data that will guide clinical practice guidelines and product inserts regarding the safety and efficacy of DOACs in cancer patients."
93,"<|user|>
The summary is informative, but can you please add some information on the potential implications of the study findings for the treatment of bronchiectasis and whether the results could change current clinical practices? Also, is there any information on the estimated sample size and duration of the study?"
94,"<|user|>
Could you provide a brief explanation of how the study will quantify differences in immune cell populations and activity between the participant groups?"
95,"<|assistant|>
The clinical trial titled ""Feasibility of Inpatient Technology Enriched Stroke Rehabilitation During the Acute and Sub-acute Phase After Stroke"" aims to test the feasibility of a technology-based, holistic rehabilitation model for stroke patients in the acute and sub-acute phase. The study will be conducted on inpatients with a diagnosis of stroke at the University Hospital Wishaw in Scotland, who are medically fit for rehabilitation and deemed to require rehabilitation. Commercially available technology, such as robotics, adapted treadmills, virtual reality, and mobile devices, will be used to enhance therapy and allow patients to work on physical, cognitive, visual, and communication goals without one-to-one treatment from a therapist. The study's primary outcomes will include the duration of time spent on activities within the 'technology enriched rehabilitation space,' movement repetitions completed within the 'technology enriched rehabilitation' sessions, rates of recruitment and attrition, and adherence to sessions. Secondary outcomes will include intervention acceptability, assessed through audio-recorded semi-structured interviews with participants, family/carers, and NHS staff. The study will follow Medical Research Council recommendations for developing a complex intervention and will be conducted in accordance with the Declaration of Helsinki. The study design is a feasibility study with a convenience sample, and the intervention model is single group assignment (open label). The study seeks to determine the potential of technology-based rehabilitation to bridge the gap between recommended levels of rehabilitation intensity and current provision for stroke patients in the acute and sub-acute phase."
96,"<|user|>
Can you summarize the main findings or results expected from this study on immersive virtual reality for persistent dyspnea in ALS patients treated with non-invasive ventilation?"
97,"<|assistant|>
The study ""Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs"" aims to evaluate the impact of a selective reporting for antibiotic susceptibility testing on GPs' prescribing of broad-spectrum antibiotics in women with E. Coli urinary tract infections (UTIs). Participants are women with E. Coli-positive urine cultures affiliated with certain healthcare centers in Loire Atlantique and Maine et Loire regions who also received antibiotic prescriptions from general practitioners during the study period. The intervention involves providing GPs with a selective antibiotic susceptibility testing report that highlights narrower-spectrum antibiotics based on four E. Coli susceptibility profiles. The primary endpoint is the rate of broad-spectrum antibiotic dispensing, and secondary endpoints include modifications in antibiotic therapy, antibiotic de-escalation rate, GP and patient characteristics, and E. Coli antimicrobial susceptibility profiles. The study is randomized, with participants allocated to either the intervention or control arm. The control arm receives a standard antibiotic susceptibility testing report. The outcomes will be measured over a 5-day period around the date of antibiotic susceptibility testing reporting. The study focuses on antibiotic therapy, primary care, and public health, specifically targeting general practitioners and women with E. Coli UTIs."
98,"<|user|>
Can you provide more details on how sodium valproate affects neuroinflammation in acute ischemic stroke? Also, could you elaborate on the mechanism behind sodium valproate's neuroprotective effect?"
99,"<|assistant|>
This study, titled ""Does a Virtual Coach Offer a Better Solution for Weight Reduction in Ventral Hernia Patients With Obesity?"", aims to compare the effectiveness of a MyChart enabled virtual weight loss coach to standard preoperative weight loss tools for ventral hernia patients with obesity. The study enrolls participants aged 18-90 with a BMI of 30 or above and scheduled for elective ventral hernia repair. The primary outcome measure is the amount of weight lost at the 6-month mark, while secondary outcomes include the number of interactions with the virtual coach, quality of life measured via a self-reported questionnaire, and satisfaction with the virtual coach. This is a non-randomized parallel assignment trial with no masking."
100,"<|user|>
Here is a abstract for the study mentioned in the text: Exo-CD24, a combination of exosomes and CD24 protein, has shown promising results in early clinical trials for treating severe COVID-19 patients. However, most clinical trials on stem cell-derived exosomes for COVID-19 treatment have some issues such as small sample size, lack of a control group, use of traditional two-dimensional production methods, making it difficult to effectively demonstrate the advantages of stem cell exosomes in COVID-19 treatment, lack of in-depth mechanism exploration for relevant phenomena, and it hinders the progress in the use of stem cell exosomes for COVID-19 infection treatment. This study aims to evaluate the safety and effectiveness of umbilical cord mesenchymal stem cell-derived exosomes (nebulized) combined with conventional therapy for the treatment of moderate, severe, and critically ill COVID-19 patients through a multicenter, randomized controlled, single-blind clinical trial.

Can you summarize the limitations of existing clinical trials on stem cell-derived exosomes for COVID-19 treatment and explain how this new study aims to address them?"
101,"<|assistant|>
This clinical trial compares the effectiveness of two root canal sealer materials, calcium silicate-based sealers (CSS) and epoxy resin-based sealers (ERS). The study aims to assess the clinical outcomes, pain intensity, pain relief, and treatment outcome evaluation over time after a single-visit root canal treatment in adults with irreversible pulpitis diagnosed through electrical and thermal tests. The study design is a randomized parallel assignment with masking, and both treatments adhere to the Vietnamese Ministry of Health's endodontic treatment protocol with the support of 3D imaging equipment and an endodontic machine. The primary outcomes are measured using a 170-mm Heft-Parker self-assessment scale and Strindberg's criteria of clinical symptoms to evaluate pain intensity, pain relief, and treatment outcome evaluation, respectively, at different time points after treatment. Keywords associated with this study include calcium silicate-based sealer and epoxy resin-based sealer."
102,"<|assistant|>
This is a multicenter cohort study in China evaluating the immunogenicity of two domestically produced bivalent HPV vaccines (Wozehui and Cecolin) versus imported HPV vaccines in adolescent girls aged 13-14. A total of 3,000 participants were recruited and followed up at 12 and 36 months after their last HPV vaccine dose. Blood samples were collected at three time points to test for HPV types 16 and 18 neutralizing antibodies. The primary outcome measures are the neutralization antibody geometric mean titers (GMT) and antibody positivity at baseline, 12 months, and 36 months. The study aims to compare the immunogenicity of the domestic and imported vaccines in this population."
103,"<|user|>
Can you provide more information about the study design and how participants will be selected and followed up? Also, is there any information on how long the study will last?"
104,"<|assistant|>
This clinical trial, titled ""Description of Septic Thrombophlebitis on Central Venous Catheter and Midline,"" aims to diagnose and monitor the duration of septic thrombophlebitis in adult hospitalized patients with central venous devices or midlines who have catheter-related bacteremia. Doppler ultrasound will be used to evaluate the signs of thrombophlebitis at specific timepoints (D8, D15, D30, D45, D60, and D90). The study does not involve any intervention and has a primary outcome measure of the duration of ultrasound signs of septic thrombophlebitis. Eligible participants must be 18 years or older, hospitalized at CHM or CHUA, consent to the study, have central venous devices or midlines with catheter-related bacteremia, and be transportable for ultrasound or able to provide consent (if incapable at the time of inclusion). The study design is non-randomized, parallel assignment, and open label (no masking). Key keywords associated with this study include septic thrombophlebitis and Doppler ultrasound."
105,"<|assistant|>
The study titled ""A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Participants With Follicular Lymphoma and Marginal Zone Lymphoma"" aims to evaluate the safety and efficacy of a bispecific antibody called odronextamab, given in combination with lenalidomide, compared to rituximab with lenalidomide in individuals with relapsed or refractory follicular lymphoma or marginal zone lymphoma. The study has two parts: Part 1, which is a safety run-in, and Part 2, which is a randomized phase. In Part 1, odronextamab and lenalidomide will be administered to participants to determine dose-limiting toxicities and treatment-emergent adverse events, along with the concentrations of odronextamab in serum, the incidence and titer of antibodies to odronextamab, and the incidence of neutralizing antibodies against odronextamab. The secondary outcome measures include response rates, durations of response, progression-free survival, overall survival, event-free survival, time to next anti-lymphoma treatment, and patient-reported outcomes assessed by several questionnaires. In Part 2, participants will be randomly assigned to receive odronextamab and lenalidomide (Olymipia-5) or rituximab followed by lenalidomide (R2) for progression-free survival, response rates, adverse events, patient-reported outcomes, and overall survival. The study enrolls individuals with histologically confirmed follicular lymphoma or marginal zone lymphoma (nodal, splenic, or extranodal) who are refractory to at least two prior chemo-immunotherapy regimens or have disease relapse after two cycles of prior therapy. The study aims to improve our understanding of the safety and efficacy of odronextamab, a new potential cancer treatment, compared to current treatments."
106,"<|assistant|>
This clinical trial, titled ""Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)"", involves four treatment groups: two receiving varying doses of the supplement Proliverenol and two receiving a placebo. The study aims to assess the effect of Proliverenol on liver function in individuals with NAFLD, as measured by changes in serum ALT and AST levels, over a 12-week period. The trial participants, aged 18 or older with a diagnosis of NAFLD, will be randomly assigned to one of the treatment groups and evaluated at four-week intervals. Both the participants and study team will be blinded to the assigned treatment, and safety profiles will be monitored throughout the study. Secondary outcomes include changes in Controlled Attenuated Parameter (CAP) and Transient elastography (TE) measurements, as well as the AST to ALT ratio. The trial is being conducted at the Centre Hospitalier Valida."
107,"<|user|>
Can you provide a brief explanation of how ozone therapy is applied during non-surgical periodontal treatment?"
